Rationale and design of the Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial

Background Patients undergoing cardiovascular procedures remain at increased risk for myocardial infarction, stroke, and cardiovascular death. Risk factor control in this patient population remains suboptimal and would likely benefit from strategies targeting education, lifestyle, and healthy behavi...

Full description

Saved in:
Bibliographic Details
Published in:The American heart journal 2015-09, Vol.170 (3), p.430-437.e9
Main Authors: Gianos, Eugenia, MD, Schoenthaler, Antoinette, EdD, MA, Mushailov, Michael, MS, Fisher, Edward A., MD, PhD, Berger, Jeffrey S., MD, MS
Format: Article
Language:English
Subjects:
Blood pressure
Cardiology
Cardiovascular
Cardiovascular Diseases - prevention & control
Cholesterol
Diabetes
Disease Management
Disease prevention
Education
Family medical history
Female
Health risk assessment
Heart attacks
Humans
Hypertension
Informed consent
Intubation
Lifestyles
Male
Middle Aged
Motivational Interviewing - organization & administration
Nutrition research
Prospective Studies
Randomized Controlled Trials as Topic - methods
Smoking cessation
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Patients undergoing cardiovascular procedures remain at increased risk for myocardial infarction, stroke, and cardiovascular death. Risk factor control in this patient population remains suboptimal and would likely benefit from strategies targeting education, lifestyle, and healthy behaviors. Design The IMPACT trial is a 400-subject prospective randomized trial designed to compare different cardiovascular prevention strategies in subjects following a cardiovascular intervention. The trial began enrollment in the Spring of 2012 and is randomizing subjects in a 1:1:1 manner to usual care, a one-time cardiovascular prevention consult, or a one-time cardiovascular prevention consult plus behavioral intervention program (telephone-based motivational interviewing and tailored text messages) over a 6-month period. The primary end point is non–high-density lipoprotein cholesterol. Secondary end points include other plasma lipid values, metabolic risk, smoking cessation, physical activity, dietary intake, medication use and adherence, and quality of life. Conclusions The IMPACT trial provides data on different management strategies for risk factor optimization in subjects following cardiovascular procedures. The results will provide a platform for the continued development of novel multidisciplinary interventions in this high-risk population.
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2015.06.001